메뉴 건너뛰기




Volumn 54, Issue 3, 2016, Pages 193-199

Effects of UGT1A1∗6, UGT1A1∗28, and ABCB1-3435C>T polymorphisms on irinotecaninduced toxicity in Chinese cancer patients

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GLUCURONOSYLTRANSFERASE 1A1; IRINOTECAN; MULTIDRUG RESISTANCE PROTEIN 1; ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; GLUCURONOSYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN; UGT1A1 ENZYME;

EID: 84962301190     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP202442     Document Type: Article
Times cited : (9)

References (38)
  • 3
    • 67449084936 scopus 로고    scopus 로고
    • Phase i study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study
    • CrossRef PubMed
    • Yamamoto K, Kokawa K, Umesaki N, Nishimura R, Hasegawa K, Konishi I, Saji F, Nishida M, Noguchi H, Takizawa K. Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study. Oncol Rep. 2009; 21: 1005-1009. CrossRef PubMed
    • (2009) Oncol Rep. , vol.21 , pp. 1005-1009
    • Yamamoto, K.1    Kokawa, K.2    Umesaki, N.3    Nishimura, R.4    Hasegawa, K.5    Konishi, I.6    Saji, F.7    Nishida, M.8    Noguchi, H.9    Takizawa, K.10
  • 4
    • 33847663871 scopus 로고    scopus 로고
    • Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study
    • PubMed
    • Pinto C, Di Fabio F, Siena S, Cascinu S, Rojas Llimpe FL, Ceccarelli C, Mutri V, Giannetta L, Giaquinta S, Funaioli C, et al. Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Ann Oncol. 2007; 18: 510-517. PubMed
    • (2007) Ann Oncol. , vol.18 , pp. 510-517
    • Pinto, C.1    Di Fabio, F.2    Siena, S.3    Cascinu, S.4    Rojas Llimpe, F.L.5    Ceccarelli, C.6    Mutri, V.7    Giannetta, L.8    Giaquinta, S.9    Funaioli, C.10
  • 5
    • 78649307699 scopus 로고    scopus 로고
    • Pharmacogenetics of irinotecan disposition and toxicity: A review
    • CrossRef PubMed
    • Fujita K, Sparreboom A. Pharmacogenetics of irinotecan disposition and toxicity: A review. Curr Clin Pharmacol. 2010; 5: 209-217. CrossRef PubMed
    • (2010) Curr Clin Pharmacol. , vol.5 , pp. 209-217
    • Fujita, K.1    Sparreboom, A.2
  • 6
    • 77954380404 scopus 로고    scopus 로고
    • Irinotecan pharmacogenomics
    • CrossRef PubMed
    • Marsh S, Hoskins JM. Irinotecan pharmacogenomics. Pharmacogenomics. 2010; 11: 1003-1010. CrossRef PubMed
    • (2010) Pharmacogenomics. , vol.11 , pp. 1003-1010
    • Marsh, S.1    Hoskins, J.M.2
  • 7
    • 77949629690 scopus 로고    scopus 로고
    • An overview of the recent progress in irinotecan pharmacogenetics
    • CrossRef PubMed
    • Fujiwara Y, Minami H. An overview of the recent progress in irinotecan pharmacogenetics. Pharmacogenomics. 2010; 11: 391-406. CrossRef PubMed
    • (2010) Pharmacogenomics. , vol.11 , pp. 391-406
    • Fujiwara, Y.1    Minami, H.2
  • 9
    • 77949755095 scopus 로고    scopus 로고
    • Phase i study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1∗28 polymorphism
    • CrossRef PubMed
    • Hazama S, Nagashima A, Kondo H, Yoshida S, Shimizu R, Araki A, Yoshino S, Okayama N, Hinoda Y, Oka M. Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1∗28 polymorphism. Cancer Sci. 2010; 101: 722-727. CrossRef PubMed
    • (2010) Cancer Sci. , vol.101 , pp. 722-727
    • Hazama, S.1    Nagashima, A.2    Kondo, H.3    Yoshida, S.4    Shimizu, R.5    Araki, A.6    Yoshino, S.7    Okayama, N.8    Hinoda, Y.9    Oka, M.10
  • 10
    • 79959815649 scopus 로고    scopus 로고
    • Assessment of total bilirubin or SN-38/SN-38G ratio as a predictor of severe irinotecan tox icity
    • PubMed
    • Tanaka H, Saito K, Mino K, Izumi K, Harada M, Isobe H. [Assessment of total bilirubin or SN-38/SN-38G ratio as a predictor of severe irinotecan tox icity]. Gan To Kagaku Ryoho. 2009; 36: 1505-1509. PubMed
    • (2009) Gan to Kagaku Ryoho. , vol.36 , pp. 1505-1509
    • Tanaka, H.1    Saito, K.2    Mino, K.3    Izumi, K.4    Harada, M.5    Isobe, H.6
  • 12
    • 0032519431 scopus 로고    scopus 로고
    • Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes
    • CrossRef PubMed
    • Iyer L, King CD, Whitington PF, Green MD, Roy SK, Tephly TR, Coffman BL, Ratain MJ. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest. 1998; 101: 847-854. CrossRef PubMed
    • (1998) J Clin Invest. , vol.101 , pp. 847-854
    • Iyer, L.1    King, C.D.2    Whitington, P.F.3    Green, M.D.4    Roy, S.K.5    Tephly, T.R.6    Coffman, B.L.7    Ratain, M.J.8
  • 16
    • 34547788826 scopus 로고    scopus 로고
    • Role of UGT1A1∗6 UGT1A1∗28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    • Cross-Ref PubMed
    • Jada SR, Lim R, Wong CI, Shu X, Lee SC, Zhou Q, Goh BC, Chowbay B. Role of UGT1A1∗6, UGT1A1∗28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci. 2007; 98: 1461-1467. Cross-Ref PubMed
    • (2007) Cancer Sci. , vol.98 , pp. 1461-1467
    • Jada, S.R.1    Lim, R.2    Wong, C.I.3    Shu, X.4    Lee, S.C.5    Zhou, Q.6    Goh, B.C.7    Chowbay, B.8
  • 17
    • 0032718482 scopus 로고    scopus 로고
    • Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates
    • CrossRef PubMed
    • Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics. 1999; 9: 591-599. CrossRef PubMed
    • (1999) Pharmacogenetics. , vol.9 , pp. 591-599
    • Hall, D.1    Ybazeta, G.2    Destro-Bisol, G.3    Petzl-Erler, M.L.4    Di Rienzo, A.5
  • 18
    • 79960535705 scopus 로고    scopus 로고
    • Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs
    • CrossRef PubMed
    • Sai K, Saito Y. Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs. Expert Opin Drug Metab Toxicol. 2011; 7: 967-988. CrossRef PubMed
    • (2011) Expert Opin Drug Metab Toxicol. , vol.7 , pp. 967-988
    • Sai, K.1    Saito, Y.2
  • 19
  • 21
  • 24
    • 34250825286 scopus 로고    scopus 로고
    • Associations of ABCB1 ABCC2 and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
    • Cross-Ref PubMed
    • Han JY, Lim HS, Yoo YK, Shin ES, Park YH, Lee SY, Lee JE, Lee DH, Kim HT, Lee JS. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer. 2007; 110: 138-147. Cross-Ref PubMed
    • (2007) Cancer. , vol.110 , pp. 138-147
    • Han, J.Y.1    Lim, H.S.2    Yoo, Y.K.3    Shin, E.S.4    Park, Y.H.5    Lee, S.Y.6    Lee, J.E.7    Lee, D.H.8    Kim, H.T.9    Lee, J.S.10
  • 26
    • 42449139713 scopus 로고    scopus 로고
    • UGT1A1∗28 polymorphism predicts irinotecaninduced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma
    • CrossRef PubMed
    • Liu CY, Chen PM, Chiou TJ, Liu JH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS. UGT1A1∗28 polymorphism predicts irinotecaninduced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Cancer. 2008; 112: 1932-1940. CrossRef PubMed
    • (2008) Cancer. , vol.112 , pp. 1932-1940
    • Liu, C.Y.1    Chen, P.M.2    Chiou, T.J.3    Liu, J.H.4    Lin, J.K.5    Lin, T.C.6    Chen, W.S.7    Jiang, J.K.8    Wang, H.S.9    Wang, W.S.10
  • 28
    • 84877737684 scopus 로고    scopus 로고
    • UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    • CrossRef PubMed
    • Gao J, Zhou J, Li Y, Lu M, Jia R, Shen L. UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients. Med Oncol. 2013; 30: 604. CrossRef PubMed
    • (2013) Med Oncol. , vol.30 , pp. 604
    • Gao, J.1    Zhou, J.2    Li, Y.3    Lu, M.4    Jia, R.5    Shen, L.6
  • 29
    • 77953289476 scopus 로고    scopus 로고
    • Dose-dependent association between UGT1A1∗28 polymorphism and irinotecan-induced diarrhoea: A meta-analysis
    • CrossRef PubMed
    • Hu ZY, Yu Q, Zhao YS. Dose-dependent association between UGT1A1∗28 polymorphism and irinotecan-induced diarrhoea: A meta-analysis. Eur J Cancer. 2010; 46: 1856-1865. CrossRef PubMed
    • (2010) Eur J Cancer. , vol.46 , pp. 1856-1865
    • Hu, Z.Y.1    Yu, Q.2    Zhao, Y.S.3
  • 30
    • 34748857912 scopus 로고    scopus 로고
    • Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations
    • Cross-Ref PubMed
    • Zhang A, Xing Q, Qin S, Du J, Wang L, Yu L, Li X, Xu L, Xu M, Feng G, He L. Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations. Pharmacogenomics J. 2007; 7: 333-338. Cross-Ref PubMed
    • (2007) Pharmacogenomics J. , vol.7 , pp. 333-338
    • Zhang, A.1    Xing, Q.2    Qin, S.3    Du, J.4    Wang, L.5    Yu, L.6    Li, X.7    Xu, L.8    Xu, M.9    Feng, G.10    He, L.11
  • 31
    • 84898058478 scopus 로고    scopus 로고
    • Associations between UGT1A1∗6 or UGT1A1∗6/∗28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    • CrossRef PubMed
    • Han FF, Guo CL, Yu D, Zhu J, Gong LL, Li GR, Lv YL, Liu H, An GY, Liu LH. Associations between UGT1A1∗6 or UGT1A1∗6/∗28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients. Cancer Chemother Pharmacol. 2014; 73: 779-788. CrossRef PubMed
    • (2014) Cancer Chemother Pharmacol. , vol.73 , pp. 779-788
    • Han, F.F.1    Guo, C.L.2    Yu, D.3    Zhu, J.4    Gong, L.L.5    Li, G.R.6    Lv, Y.L.7    Liu, H.8    An, G.Y.9    Liu, L.H.10
  • 33
    • 84896051392 scopus 로고    scopus 로고
    • UGT1A1∗6 polymorphisms are correlated with irinotecan-induced toxicity: A system review and meta-analysis in Asians
    • CrossRef PubMed
    • Cheng L, Li M, Hu J, Ren W, Xie L, Sun ZP, Liu BR, Xu GX, Dong XL, Qian XP. UGT1A1∗6 polymorphisms are correlated with irinotecan-induced toxicity: A system review and meta-analysis in Asians. Cancer Chemother Pharmacol. 2014; 73: 551-560. CrossRef PubMed
    • (2014) Cancer Chemother Pharmacol. , vol.73 , pp. 551-560
    • Cheng, L.1    Li, M.2    Hu, J.3    Ren, W.4    Xie, L.5    Sun, Z.P.6    Liu, B.R.7    Xu, G.X.8    Dong, X.L.9    Qian, X.P.10
  • 35
    • 84897383948 scopus 로고    scopus 로고
    • Association of UGT1A1∗28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: A meta-analysis in Caucasians
    • CrossRef PubMed
    • Liu X, Cheng D, Kuang Q, Liu G, Xu W. Association of UGT1A1∗28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: A meta-analysis in Caucasians. Pharmacogenomics J. 2014; 14: 120-129. CrossRef PubMed
    • (2014) Pharmacogenomics J. , vol.14 , pp. 120-129
    • Liu, X.1    Cheng, D.2    Kuang, Q.3    Liu, G.4    Xu, W.5
  • 36
    • 0037229942 scopus 로고    scopus 로고
    • Role of P-glycoprotein in pharmacokinetics: Clinical implications
    • CrossRef PubMed
    • Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: Clinical implications. Clin Pharmacokinet. 2003; 42: 59-98. CrossRef PubMed
    • (2003) Clin Pharmacokinet. , vol.42 , pp. 59-98
    • Lin, J.H.1    Yamazaki, M.2
  • 38
    • 84865342457 scopus 로고    scopus 로고
    • Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients
    • CrossRef PubMed
    • Cortejoso L, López-Fernández LA. Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients. Pharmacogenomics. 2012; 13: 1173-1191. CrossRef PubMed
    • (2012) Pharmacogenomics. , vol.13 , pp. 1173-1191
    • Cortejoso, L.1    López-Fernández, L.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.